DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering

Rhea-AI Summary

DSS (NYSE American: DSS) closed a firm commitment underwritten public offering, generating approximately $1.0 million in gross proceeds from the sale of 900,000 shares of common stock at $1.00 per share. An underwriter overallotment option covers up to 135,000 additional shares (15%). Net proceeds are expected to be used for general corporate purposes, including working capital. The offering was made under an effective Form S-3 (No. 333-281974) declared effective November 5, 2024, and Aegis Capital Corp. acted as book-running manager.

Key Figures

Gross proceeds: $1.0 million Offering size: 900,000 shares Offering price: $1.00 per share +5 more

8 metrics

Gross proceeds $1.0 million Underwritten public offering gross proceeds before fees

Offering size 900,000 shares Shares of common stock sold in the offering

Offering price $1.00 per share Public offering price of common stock

Overallotment shares 135,000 shares Additional shares available under overallotment option (15%)

Overallotment percentage 15% Portion of base offering size subject to overallotment

Registration number 333-281974 Form S-3 shelf registration statement reference

Shelf filing date October 31, 2024 Date Form S-3 filed with SEC as cited in release

Effectiveness date November 5, 2024 Date Form S-3 declared effective by SEC

Market Reality Check

Price: $0.8901 Vol: Volume 806,211 is 3.22x t...

high vol

$0.8901 Last Close

Volume Volume 806,211 is 3.22x the 20-day average of 250,412, indicating elevated trading activity ahead of this closing. high

Technical Shares at $0.94 are trading below the 200-day MA of $1.06 after a -32.37% move over 24 hours.

Peers on Argus

DSS fell 32.37% while key peers showed mixed moves: OCTO dropped 36.06%, YHGJ sl...

DSS fell 32.37% while key peers showed mixed moves: OCTO dropped 36.06%, YHGJ slipped 2.76%, TRS edged down 0.26%, and MGIH/MYE rose 0.57% and 2.01%. This points to a DSS-specific reaction to its offering.

Previous Offering Reports

2 past events · Latest: Feb 04 (Negative)

Same Type Pattern 2 events

Date	Event	Sentiment	Move	Catalyst
Feb 04	Offering priced	Negative	-32.4%	Pricing of 900,000-share underwritten public offering at $1.00 per share.
Feb 03	Offering launched	Negative	+17.8%	Announcement of proposed public offering for general corporate and working capital.

Pattern Detected

Recent offering-related headlines have produced mixed reactions, with one sharp selloff and one notable bounce, indicating inconsistent trading around capital raises.

Recent Company History

Over the last few days, DSS has issued a series of offering-tagged announcements. On Feb 3, 2026, it launched a proposed public offering, which coincided with a 17.8% gain. On Feb 4, 2026, pricing of the $1.0 million underwritten deal and 900,000 shares led to a -32.37% reaction. Today’s closing announcement follows directly from that sequence, formalizing terms already disclosed.

Historical Comparison

offering

-7.3 %

Average Historical Move

Historical Analysis

In recent days, DSS disclosed two offering-related updates with an average move of -7.28%. Today’s closing formalizes previously priced terms, fitting into this short-term capital-raise cycle.

Typical Pattern

Sequence of offering events progressed from proposed deal launch to pricing, and now to formal closing of the underwritten public offering.

Market Pulse Summary

This announcement confirms the closing of DSS’s underwritten public offering, raising gross proceeds...

Analysis

This announcement confirms the closing of DSS’s underwritten public offering, raising gross proceeds of $1.0 million via 900,000 shares at $1.00, plus a 135,000-share overallotment option. It follows recent launch and pricing updates tagged as offerings, which produced volatile reactions. Investors monitoring this name may focus on how these funds support working capital, ongoing losses, and liquidity risks highlighted in recent SEC filings.

Key Terms

firm commitment underwritten public offering, overallotment option, shelf registration statement, form s-3, +1 more

5 terms

firm commitment underwritten public offering financial

"announced the closing of its previously announced firm commitment underwritten public offering."

A firm commitment underwritten public offering is when an investment bank agrees to buy all new shares from a company at an agreed price and then resell them to investors, taking on the risk that it must sell the stock. Think of it like a retailer buying a full shipment up front so the seller is guaranteed cash. For investors, it guarantees the company will raise a specific amount but can dilute existing shareholders and affect market price depending on how the resale goes.

overallotment option financial

"granted Aegis Capital Corp., the underwriter, an overallotment option to purchase"

An overallotment option (often called a "greenshoe") is a pre-arranged allowance for underwriters to sell or buy up to a specified extra percentage of a company’s shares during an offering to meet unexpected demand or support the share price. Think of it as a short-term buffer: it helps reduce wild swings right after shares start trading but can slightly increase the total shares outstanding if the option is exercised, which matters to investors because it affects supply, price stability, and potential dilution.

shelf registration statement regulatory

"The offering was made pursuant to an effective shelf registration statement on Form S-3"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

form s-3 regulatory

"effective shelf registration statement on Form S-3 (No. 333-281974) previously filed"

Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.

prospectus supplement regulatory

"A final prospectus supplement and accompanying prospectus describing the terms"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. Not financial advice.

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $1.0 million, before deducting underwriting fees and other offering expenses payable by the Company.

The offering consisted of 900,000 shares of common stock. The public offering price per share of common stock was $1.00. In addition, the Company granted Aegis Capital Corp., the underwriter, an overallotment option to purchase up to an additional 135,000 shares of common stock, representing 15% of the number of shares sold in the offering solely to cover over-allotments, if any.

The Company expects to use the net proceeds from the offering for general corporate purposes, including working capital.

Aegis Capital Corp. acted as the sole book-running manager for the offering. Sichenzia Ross Ference Carmel LLP acted as counsel to the Company. Kaufman & Canoles, P.C. acted as counsel to Aegis Capital Corp.

The offering was made pursuant to an effective shelf registration statement on Form S-3 (No. 333-281974) previously filed with the U.S. Securities and Exchange Commission (SEC) on October 31, 2024, and declared effective by the SEC on November 5, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone at +1 (212) 813-1010.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About DSS, Inc.

DSS, Inc. (NYSE American: DSS) is a multinational company operating across multiple business lines including product packaging, biotechnology, commercial lending, and securities and investment management. The Company operates a business model based on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings. For more information, visit www.dssworld.com.

Forward-Looking Statements

The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

For investor and media inquiries or additional information, please contact:

Investor Contact:

DSS, Inc.
Investor Relations
ir@dssworld.com
+1 (585) 565-2422

FAQ

How much did DSS (DSS) raise in the February 5, 2026 public offering?

DSS raised approximately $1.0 million in gross proceeds from the offering. According to the company, the sale consisted of 900,000 shares at $1.00 per share, before underwriting fees and offering expenses.

What was the share count and price in DSS's (DSS) February 2026 offering?

The offering sold 900,000 shares of common stock at $1.00 per share. According to the company, the underwriter also received an overallotment option for up to 135,000 additional shares (15%).

Who managed the DSS (DSS) underwritten public offering and who were the counsels?

Aegis Capital Corp. acted as the sole book-running manager for the offering. According to the company, Sichenzia Ross Ference Carmel LLP advised DSS and Kaufman & Canoles advised Aegis Capital.

What will DSS (DSS) use the net proceeds from the offering for?

DSS expects to use net proceeds for general corporate purposes, including working capital. According to the company, no specific projects or allocations were disclosed in the announcement.

Where can investors find the final prospectus for DSS's (DSS) offering?

The final prospectus supplement and accompanying prospectus will be filed with the SEC and available at www.sec.gov. According to the company, electronic copies can also be requested from Aegis Capital's syndicate department.